Davis's Drug Guide
DOXOrubicin, liposomal
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
dox-oh-roo-bi-sin lye-poe-sohm-al
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Caelyx
- Doxil
Ther. Class.
Pharm. Class.
anthracyclines
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "DOXOrubicin, Liposomal." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109376/all/DOXOrubicin__liposomal.
Vallerand AHA, Sanoski CAC, Quiring CC. DOXOrubicin, liposomal. Davis's Drug Guide. F.A. Davis Company; 2023. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109376/all/DOXOrubicin__liposomal. Accessed May 29, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). DOXOrubicin, liposomal. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109376/all/DOXOrubicin__liposomal
Vallerand AHA, Sanoski CAC, Quiring CC. DOXOrubicin, Liposomal [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 May 29]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109376/all/DOXOrubicin__liposomal.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - DOXOrubicin, liposomal
ID - 109376
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.unboundmedicine.com/washingtonmanual/view/Davis-Drug-Guide/109376/all/DOXOrubicin__liposomal
PB - F.A. Davis Company
ET - 18
DB - The Washington Manual
DP - Unbound Medicine
ER -
